VMAC-Ab1

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameVMAC-Ab1
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVMAC Immunotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVMAC Immunotech
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsPancreatic NeoplasmsColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A